![Kerri-Ann Millar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Kerri-Ann Millar formerly worked at Flexion Therapeutics, Inc., as Controller from 2014 to 2017 and Cue Biopharma, Inc., as Chief Financial Officer from 2020 to 2025.
Ms. Millar received her undergraduate degree in 1992 from Boston University.
Eerdere bekende functies van Kerri-Ann Millar
| Bedrijven | Functie | Einde |
|---|---|---|
| CUE BIOPHARMA, INC. | Financieel Directeur/CFO | 13-06-2025 |
| FLEXION THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-09-2017 |
Opleiding van Kerri-Ann Millar
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
95
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
